Lightnews — Scholar-powered news

Reposted by Dr. Jaime Imitola, MD FAAN

Dr. Jaime Imitola, MD FAAN @drjim4ms.bsky.social · Mar 7

MS prevalence in #Connecticut is very high and every Friday in #March, our team is increasing awareness to our @uconnhealth.bsky.social employees, staff and visitors. . #MSvisibl @mssociety.bsky.social @uconnhealth.bsky.social #MScafe

1 1 1

Dr. Jaime Imitola, MD FAAN @drjim4ms.bsky.social · Mar 7

MS prevalence in #Connecticut is very high and every Friday in #March, our team is increasing awareness to our @uconnhealth.bsky.social employees, staff and visitors. . #MSvisibl @mssociety.bsky.social @uconnhealth.bsky.social #MScafe

1 1 1

Reposted by Dr. Jaime Imitola, MD FAAN

Miron Lab @mironlab.bsky.social · Feb 14

🧪The #ACTRIMS forum always has a session dedicated to ECRs to give them the opportunity to showcase their research and build their network. Here's our exciting #ACTRIMS2025 young investigator session on emerging concepts in MS, covering basic, translational and clinical science. See you there!

3 6

Reposted by Dr. Jaime Imitola, MD FAAN

Joe Sabatino @jsabatino37.bsky.social · Feb 14

AQP4-specific T cells determine lesion localization in the CNS in a model of NMOSD

actaneurocomms.biomedcentral.com/articles/10....

AQP4-specific T cells determine lesion localization in the CNS in a model of NMOSD - Acta Neuropathologica Communications

Neuromyelitis optica spectrum disorder (NMOSD) is a paradigmatic autoimmune disease of the central nervous system (CNS), in which the water channel protein Aquaporin-4 (AQP4) is targeted by a self-rea...

actaneurocomms.biomedcentral.com

2 2

Dr. Jaime Imitola, MD FAAN @drjim4ms.bsky.social · Feb 8

Our current leaders made a pledge to use "common sense" in governing. As a clinician scientist and leaders, it is unclear to us, how cutting the NIH budget that helps millions of ALL #redandblue Americans sensible, justifiable and making ANY sense. @uconnhealth.bsky.social @nature.com

1

Reposted by Dr. Jaime Imitola, MD FAAN

Gary Swergold MD, PhD @gs314.bsky.social · Jan 31

🧪
If I were Canadian PM I would immediately:

1. Create a new $15B science fund

2. Offer any credentialed US scientist funding for lab startup and replacement of NIH grants if they move to Canada

3. Immediate permanent residency

4. Citizenship after 2 years

Overnight a science superpower

1.3K 7K 41K

Dr. Jaime Imitola, MD FAAN @drjim4ms.bsky.social · Feb 1

Feb 1, is the start of our @uconnhealth.bsky.social awareness campaign for #early MS. Despite the advances,we still have unmet needs in #MS. Please share our #MS #awareness work published in @MSJ_Research and RT. @mssocietyuk.bsky.social @aanmember.bsky.social @stanfordneuro.bsky.social

3 6

Reposted by Dr. Jaime Imitola, MD FAAN

Eric Topol @erictopol.bsky.social · Jan 24

A pro-inflammatory protein panel signature that accurately identified Long Covid in kids compared with controls

www.nature.com/articles/s41...

18 97 360

Reposted by Dr. Jaime Imitola, MD FAAN

Eric Topol @erictopol.bsky.social · Jan 24

Welcome immigrants from X interested in science to the friendlier skies of @bsky.app, as documented by a new @nature.com survey (but you already knew that 😉)
"Bluesky is much better for science. There is much less toxicity, misinformation, and distractions."
www.nature.com/articles/d41...

250 2.4K 16K

Reposted by Dr. Jaime Imitola, MD FAAN

Ruth Dobson @drruthdobson.bsky.social · Jan 24

It's been a busy time in the MS group in the Centre for Preventive Neurology! We've put together a newsletter to update where we're up to, opportunities to input into and take part in research, and highlight some of our fantastic PhD students. mailchi.mp/4672ff6ce37d...

Centre for Preventive Neurology Newsletter

mailchi.mp

6 7

Reposted by Dr. Jaime Imitola, MD FAAN

The MS Wire @themswire.bsky.social · Jan 16

Tolebrutinib on a fast track towards final FDA approval to treat #SPMS. #MS themswire.com/tolebrutinib...

Tolebrutinib nears the MS approval finish line - The MS Wire

Tolebrutinib is a disease-modifying therapy on the brink of being approved to fight multiple sclerosis. Fingers crossed that it is.

themswire.com

1 7

Reposted by Dr. Jaime Imitola, MD FAAN

Lucas Schirmer @lschirmer.bsky.social · Dec 26

Happy holidays with a new review about what glial cells are doing in MS patholoy featuring latest developments and tools, thanks @kooistrasm.bsky.social for teaming up and putting this together - have fun reading: onlinelibrary.wiley.com/doi/10.1002/...

Multiple Sclerosis: Glial Cell Diversity in Time and Space

Glial cells and their subtypes are key drivers of lesion progression in multiple sclerosis with roles in both tissue damage and repair depending on the surrounding tissue environment and the function....

onlinelibrary.wiley.com

2 8 22

Reposted by Dr. Jaime Imitola, MD FAAN

The American Journal of Neuroradiology @theajnr.bsky.social · Dec 27

"CNS Vasculitis in Autoimmune Disease: MR Imaging Findings and Correlation with Angiography"

doi.org/10.3174/ajnr...

1 1 2

Reposted by Dr. Jaime Imitola, MD FAAN

Dr. Jaime Imitola, MD FAAN @drjim4ms.bsky.social · Dec 24

Great Nature article building momentum to the transition of stem cells to the bedside, with this in mind @ISSCR
launched the first-of-its Kind Continuing Education Course on Stem Cell-Based Medicine, translation of stem cell is our next goal.

www.nature.com/articles/d41...

Stem cells head to the clinic: treatments for cancer, diabetes and Parkinson’s disease could soon be here

More than 100 clinical trials put stem cells for regenerative medicine to the test. It’s a turning point for a field beset with ethical and political controversy.

www.nature.com

1 1 1

Dr. Jaime Imitola, MD FAAN @drjim4ms.bsky.social · Dec 24

I am very excited to be part of the International team building this first of its kind continuing medical education for physicians worldwide. #ISSCR
#Nature isscr.org/isscr-news/c...

ISSCR Creates First-of-its Kind Continuing Education Course on Stem Cell-Based Medicine — International Society for Stem Cell Research

Clinicians will soon gain access to trusted education on stem cell-based therapies through a new Continuing Education (CE) course developed by the International Society of Stem Cell Research (ISSCR). ...

isscr.org

Dr. Jaime Imitola, MD FAAN @drjim4ms.bsky.social · Dec 24

Great Nature article building momentum to the transition of stem cells to the bedside, with this in mind @ISSCR
launched the first-of-its Kind Continuing Education Course on Stem Cell-Based Medicine, translation of stem cell is our next goal.

www.nature.com/articles/d41...

Stem cells head to the clinic: treatments for cancer, diabetes and Parkinson’s disease could soon be here

More than 100 clinical trials put stem cells for regenerative medicine to the test. It’s a turning point for a field beset with ethical and political controversy.

www.nature.com

1 1 1

Reposted by Dr. Jaime Imitola, MD FAAN

Ali Christy, MD, PhD @oligoclonalband.medsky.social · Dec 19

Neurology just lost a true legend and trailblazer.

Ana Judith Román-García (1930-2024)

The 1st female neurologist in Puerto Rico and one of the 1st Black women to complete a neurology residency
1/10
#NeuroSky #MedSky www.elnuevodia.com/noticias/loc...

“A mí me enseñaron que la salud es el paciente”

Entrevista con Ana Judith Román, la primera mujer neuróloga en Puerto Rico

www.elnuevodia.com

1 10 30

Reposted by Dr. Jaime Imitola, MD FAAN

Kuchroo Lab @kuchroolab.bsky.social · Dec 18

Excited to share that our PI Vijay Kuchroo will be awarded the 2025 AAI-Thermo Fisher Meritorious Career Award, for outstanding research contributions to immunology. He’ll be presented the award & giving a lecture in Honolulu at the annual @immunologyaai.bsky.social meeting in May. 🧪
Congrats Vijay!

1 1 15

Reposted by Dr. Jaime Imitola, MD FAAN

🦋 M.S. MotorcycleMama 🏍️༄₊°.࿔ ༘. ⃛ @ms-motorcyclemama.bsky.social · Dec 19

🧡 🧡 This Is MS 🧡 🧡

#MSAwareness #InvisibleIllness #Disability #MSWarrior #MSStrong 💪🏻

#MSWontStopUs

“Living with #MultipleSclerosis requires an intricate balance between ignoring your symptoms to live
and listening to your body to survive.”

#ThisIsMS

#MSAwareness #InvisibleIllness #Disability #MSWarrior #MSStrong

#MSWontStopUs

2 17 61

Reposted by Dr. Jaime Imitola, MD FAAN

SM @sdkm.bsky.social · Dec 18

Rebound relapse after cessation of NTZ. Happened to me, still recovering 12 months on. Kesimpta has been the stabilising factor so far #MS #MultipleSclerosis #Natalizumab #Kesimpta #Ofatumumab

onlinelibrary.wiley.com/doi/full/10....

Catastrophic outcome of patients with a rebound after Natalizumab treatment discontinuation

In this article, we presented four cases and analyzed the actual evidence of rebound after Natalizumab (NTZ) withdrawal, clinical and radiological features are discussed. We think it is important to ...

onlinelibrary.wiley.com

4 2 5

Reposted by Dr. Jaime Imitola, MD FAAN

Eric Topol @erictopol.bsky.social · Dec 17

"Why does the brain need billions of neurons to process 10 bits/second? Why can we only think about one thing at a time?"
www.cell.com/neuron/fullt...

From The Unbearable Slowness of Being

32 110 520

Reposted by Dr. Jaime Imitola, MD FAAN

Multiple Sclerosis @multiplesclerosis.bsky.social · Dec 17

Can a computer tell patients how their multiple sclerosis will progress?
patienttalk.org/can-a-comput...

3 3

Reposted by Dr. Jaime Imitola, MD FAAN

Eric Topol @erictopol.bsky.social · Dec 17

A neurologist with 2 APOE4 copies tells us about his experience with #Alzheimers disease
washingtonpost.com/wellness/202...

17 100 380

Reposted by Dr. Jaime Imitola, MD FAAN

SKY Explore @docworldexplore.bsky.social · Dec 16

First ever image of another multi-planet solar system captured by ESO Telescope

370 1.5K 14K

Reposted by Dr. Jaime Imitola, MD FAAN

theMSguide.com @themsguide.com · Dec 15

This can’t be repeated enough. MS is never inactive/not there. It is always vandalising our brains whether it is detectable by current methods or not.

This is the reason to treat it with a highly effective DMT and the full court press of lifestyle interventions as soon as poss.

1 4 8